<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36201373</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>40</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.</ArticleTitle><Pagination><StartPage>1253</StartPage><EndPage>1259</EndPage><MedlinePgn>1253-1259</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7140a1</ELocationID><Abstract><AbstractText>The New Vaccine Surveillance Network (NVSN) is a prospective, active, population-based surveillance platform that enrolls children with acute respiratory illnesses (ARIs) at seven pediatric medical centers. ARIs are caused by respiratory viruses including influenza virus, respiratory syncytial virus (RSV), human metapneumovirus (HMPV), human parainfluenza viruses (HPIVs), and most recently SARS-CoV-2 (the virus that causes COVID-19), which result in morbidity among infants and young children (1-6). NVSN estimates the incidence of pathogen-specific pediatric ARIs and collects clinical data (e.g., underlying medical conditions and vaccination status) to assess risk factors for severe disease and calculate influenza and COVID-19 vaccine effectiveness. Current NVSN inpatient (i.e., hospital) surveillance began in 2015, expanded to emergency departments (EDs) in 2016, and to outpatient clinics in 2018. This report describes demographic characteristics of enrolled children who received care in these settings, and yearly circulation of influenza, RSV, HMPV, HPIV1-3, adenovirus, human rhinovirus and enterovirus (RV/EV),* and SARS-CoV-2 during December 2016-August 2021. Among 90,085 eligible infants, children, and adolescents (children) aged &lt;18 years<sup>&#x2020;</sup> with ARI, 51,441 (57%) were enrolled, nearly 75% of whom were aged &lt;5 years; 43% were hospitalized. Infants aged &lt;1 year accounted for the largest proportion (38%) of those hospitalized. The most common pathogens detected were RV/EV and RSV. Before the emergence of SARS-CoV-2, detected respiratory viruses followed previously described seasonal trends, with annual peaks of influenza and RSV in late fall and winter (7,8). After the emergence of SARS-CoV-2 and implementation of associated pandemic nonpharmaceutical interventions and community mitigation measures, many respiratory viruses circulated at lower-than-expected levels during April 2020-May 2021. Beginning in summer 2021, NVSN detected higher than anticipated enrollment of hospitalized children as well as atypical interseasonal circulation of RSV. Further analyses of NVSN data and continued surveillance are vital in highlighting risk factors for severe disease and health disparities, measuring the effectiveness of vaccines and monoclonal antibody-based prophylactics, and guiding policies to protect young children from pathogens such as SARS-CoV-2, influenza, and RSV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Ariana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lively</LastName><ForeName>Joana Y</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Curns</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Geoffrey A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Halasa</LastName><ForeName>Natasha B</ForeName><Initials>NB</Initials></Author><Author ValidYN="Y"><LastName>Staat</LastName><ForeName>Mary Allen</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Szilagyi</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Laura S</ForeName><Initials>LS</Initials></Author><Author ValidYN="Y"><LastName>McNeal</LastName><ForeName>Monica M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Clopper</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yingtao</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Whitaker</LastName><ForeName>Brett L</ForeName><Initials>BL</Initials></Author><Author ValidYN="Y"><LastName>LeMasters</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Harker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Englund</LastName><ForeName>Janet A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Eileen J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Selvarangan</LastName><ForeName>Rangaraj</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Boom</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Sahni</LastName><ForeName>Leila C</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Michaels</LastName><ForeName>Marian G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>John V</ForeName><Initials>JV</Initials></Author><Author ValidYN="Y"><LastName>Langley</LastName><ForeName>Gayle E</ForeName><Initials>GE</Initials></Author><Author ValidYN="Y"><LastName>Gerber</LastName><ForeName>Susan I</ForeName><Initials>SI</Initials></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Aron J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Rha</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>McMorrow</LastName><ForeName>Meredith</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><CollectiveName>New Vaccine Surveillance Network Collaborators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 IP001150</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001155</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001158</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001050</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001157</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001049</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029121" MajorTopicYN="Y">Metapneumovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Janet A. Englund reports support from AstraZeneca, GSK (GlaxoSmithKline), and Pfizer, Inc., and consulting fees from Sanofi Pasteur, Meissa Vaccines, and AstraZeneca. Natasha B. Halasa reports grant support from Sanofi Pasteur and Quidel and an education grant from Genetech. Christopher J. Harrison reports institutional support from GSK, Merck, and Pfizer, Inc., and honoraria from Pediatric News. Rangaraj Selvarangan reports grants from Hologic, BioFire Diagnostics, Becton Dickinson, Luminex, and Cepheid and serves on the GSK advisory board. Geoffrey A. Weinberg reports consulting fees from ReViral and honoraria from Merck for writing textbook chapters in the Merck Manual. John V. Williams reports grant support from the National Institutes of Health (for work unrelated to the report), consulting fees from Quidel&#x2019;s scientific advisory board, and honorarium from the Infectious Disease of Children for a conference presentation, participation on a GSK independent data monitoring committee and on a data safety monitoring board for the National Institute of Allergy and Infectious Diseases IMPAACT Study. No other potential conflicts of interest were disclosed.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Strelitz</LastName><ForeName>Bonnie</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Seattle Children's Hospital, Seattle, Washington.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lacombe</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Seattle Children's Hospital, Seattle, Washington.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moffatt</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Mercy, Kansas City, Missouri.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schuster</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Children's Mercy, Kansas City, Missouri.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rohlfs</LastName><ForeName>Chelsea</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Cincinnati, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Howard</LastName><ForeName>Miranda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Cincinnati, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Romero</LastName><ForeName>Yesenia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chappell</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Piedra</LastName><ForeName>Pedro A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Avadhanula</LastName><ForeName>Vasanthi</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fregoe</LastName><ForeName>Wende</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Medicine &amp; Dentistry, University of Rochester, Rochester, New York.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Albertin</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine &amp; Dentistry, University of Rochester, Rochester, New York.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hickey</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Judith M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>6</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36201373</ArticleId><ArticleId IdType="pmc">PMC9541034</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7140a1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iwane MK, Edwards KM, Szilagyi PG, et al.; New Vaccine Surveillance Network. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004;113:1758&#x2013;64. 10.1542/peds.113.6.1758</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.113.6.1758</ArticleId><ArticleId IdType="pubmed">15173503</ArticleId></ArticleIdList></Reference><Reference><Citation>Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004&#x2013;2009. Pediatrics 2013;131:207&#x2013;16. 10.1542/peds.2012-1255</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-1255</ArticleId><ArticleId IdType="pmc">PMC3557405</ArticleId><ArticleId IdType="pubmed">23296444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CB, Weinberg GA, Blumkin AK, et al. Respiratory syncytial virus&#x2013;associated hospitalizations among children less than 24 months of age. Pediatrics 2013;132:e341&#x2013;8. 10.1542/peds.2013-0303</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-0303</ArticleId><ArticleId IdType="pubmed">23878043</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards KM, Zhu Y, Griffin MR, et al.; New Vaccine Surveillance Network. Burden of human metapneumovirus infection in young children. N Engl J Med 2013;368:633&#x2013;43. 10.1056/NEJMoa1204630</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1204630</ArticleId><ArticleId IdType="pmc">PMC3662802</ArticleId><ArticleId IdType="pubmed">23406028</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg GA, Hall CB, Iwane MK, et al.; New Vaccine Surveillance Network. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr 2009;154:694&#x2013;9. 10.1016/j.jpeds.2008.11.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2008.11.034</ArticleId><ArticleId IdType="pubmed">19159905</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha B, Lively JY, Englund JA, et al. Severe acute respiratory syndrome coronavirus 2 infections in children: multicenter surveillance, United States, January&#x2013;March 2020. J Pediatric Infect Dis Soc 2020;9:609&#x2013;12. 10.1093/jpids/piaa075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa075</ArticleId><ArticleId IdType="pmc">PMC7337823</ArticleId><ArticleId IdType="pubmed">32556327</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Update: influenza activity&#x2014;United States, 1999&#x2013;2000 season. MMWR Morb Mortal Wkly Rep 2000;49:173&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11795497</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose EB, Wheatley A, Langley G, Gerber S, Haynes A. Respiratory syncytial virus seasonality&#x2014;United States, 2014&#x2013;2017. MMWR Morb Mortal Wkly Rep 2018;67:71&#x2013;6. 10.15585/mmwr.mm6702a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6702a4</ArticleId><ArticleId IdType="pmc">PMC5772804</ArticleId><ArticleId IdType="pubmed">29346336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahni LC, Avadhanula V, Ortiz CS, et al. Comparison of mid-turbinate and nasopharyngeal specimens for molecular detection of SARS-CoV-2 among symptomatic outpatients at a pediatric drive-through testing site. J Pediatric Infect Dis Soc 2021;10:872&#x2013;9. 10.1093/jpids/piab046</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piab046</ArticleId><ArticleId IdType="pubmed">34173660</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddadin Z, Schuster JE, Spieker AJ, et al. Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics 2021;148:e2021051462. 10.1542/peds.2021-051462</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-051462</ArticleId><ArticleId IdType="pmc">PMC8338906</ArticleId><ArticleId IdType="pubmed">33986150</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>